Leap Therapeutics Competitors and Similar CompaniesClear all

Leap Therapeutics's competitors and similar companies include AstraZeneca, Agenus, BeyondSpring and NiKang Therapeutics.

	Leap Therapeutics Leap Therapeutics (also known as Cypherpunk Technologies, formerly known as HealthCare Pharmaceuticals) is a biopharmaceutical company developing targeted and immuno-oncology therapeutics.	AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.	Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.	BeyondSpring BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies.	NiKang Therapeutics NiKang Therapeutics is a biotech company focused on developing small molecule oncology medicines.
Founding Date	Founding Date 2011	Founding Date 1999	Founding Date 1994	Founding Date 2010	Founding Date 2017
Type	Type Public	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma
Locations	Locations Cambridge, US HQ	Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more	Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US	Locations Florham Park, US HQ	Locations Wilmington, US HQ
Employees	Employees 688% decrease	Employees 94,300	Employees 8174% decrease	Employees 4014% increase	Employees 403% increase
Valuation ($)	Valuation ($) 176.4 m	Valuation ($) 2.7 b	Valuation ($) 96.2 m	Valuation ($) 89.4 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $58.7b (FY, 2025)	Revenue (est.) $114.2m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $4.9b (FY, 2025)	Cost of goods $1m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $54.2b (FY, 2025)	Gross profit $113.2m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income $4.8m (FY, 2025)	Net income $10.2b (FY, 2025)	Net income ($3.1m) (FY, 2025)	Net income ($16.7m) (FY, 2024)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 1b	Total funding raised $ 171.1m	Total funding raised $ 36.1m	Total funding raised $ 200m